Altimmune (ALT) EBT Margin Growth (5y) (2015 - 2025)
Altimmune (ALT) EBT Margin Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Altimmune | 571.75 Mn | 571.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22.31 Mn |
| Sep 30, 2025 | -37.97 Mn |
| Jun 30, 2025 | -44.25 Mn |
| Mar 31, 2025 | -40.48 Mn |
| Dec 31, 2024 | -46.29 Mn |
| Sep 30, 2024 | -45.52 Mn |
| Jun 30, 2024 | -49.26 Mn |
| Mar 31, 2024 | -48.78 Mn |
| Dec 31, 2023 | -8.47 Mn |
| Sep 30, 2023 | -558,949.00 |
| Jun 30, 2023 | -28.12 Mn |
| Mar 31, 2023 | -9.60 Mn |
| Dec 31, 2022 | -3.74 Mn |
| Sep 30, 2022 | -118.50 Mn |
| Jun 30, 2022 | -25.15 Mn |
| Mar 31, 2022 | -5.97 Mn |
| Dec 31, 2021 | 10,930.00 |
| Sep 30, 2021 | -2.07 Mn |
| Jun 30, 2021 | -1.78 Mn |
| Mar 31, 2021 | -165,330.00 |